American Portfolios Advisors Cellectis S.A. Transaction History

American Portfolios Advisors

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Mar 22, 2023	BUY	$11.94 - $16.09 $79,699 - $107,400	6,675 New	6,675 $84.2 Million
Q2 2021 Mar 22, 2023	BUY	$14.36 - $20.93 $95,853 - $139,707	6,675 New	6,675 $103 Million
Q1 2021 Mar 22, 2023	BUY	$18.19 - $33.25 $113,341 - $207,180	6,231 New	6,231 $126 Million
Q4 2020 Mar 22, 2023	BUY	$15.87 - $31.64 $187,805 - $374,427	11,834 New	11,834 $320 Million
Q3 2020 Mar 22, 2023	BUY	$15.7 - $20.84 $132,633 - $176,056	8,448 New	8,448 $156 Million

Q2 2020 Mar 24, 2023	BUY	$8.21 - $21.02 $20,713 - $53,033	2,523 Added 87.39%	5,410 $96.3 Million
Q1 2020 Mar 24, 2023	BUY	$7.81 - $18.82 $22,547 - $54,333	2,887 New	2,887 $26.6 Million
Q4 2019 Mar 24, 2023	BUY	$9.73 - $19.31 $2,821 - $5,599	290 New	290 $4.97 Million
Q3 2019 Mar 24, 2023	BUY	$10.15 - $16.89 $101 - $168	10 Added 3.57%	290 $3.02 Million
Q2 2019 Mar 24, 2023	BUY	$14.6 - $20.6 $4,088 - $5,768	280 New	280 $4.37 Million
Q1 2019 Mar 24, 2023	BUY	$15.53 - $19.75 $2,329 - $2,962	150 Added 53.57%	430 $7.89 Million
Q3 2018 Mar 24, 2023	BUY	$25.99 - $30.6 $7,277 - $8,568	280 New	280 $7.9 Million
Q2 2018 Mar 24, 2023	BUY	$27.78 - $38.53 $5,000 - $6,935	180 Added 180.0%	280 $7.92 Million
Q1 2018 Mar 24, 2023	BUY	$27.78 - $35.19 $2,778 - $3,519	100 New	100 $3.15 Million
Q4 2017 Mar 24, 2023	BUY	$23.33 - $35.01 $3,499 - $5,251	150	150 $4.37 Million

9.73M

30.9K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $101M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.